Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
Jian-wei Chen, Shu-qin Xie Department of Nephrology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China Objective: Depressive and anxiety symptoms could affect the quality of life and prognostic outcomes in chronic kidney disease (CKD) patients, but only a few studies...
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Dove Medical Press
2018-02-01
|
| Saila: | Neuropsychiatric Disease and Treatment |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.dovepress.com/agomelatine-versus-paroxetine-in-treating-depressive-and-anxiety-sympt-peer-reviewed-article-NDT |